Onxeo has engaged MCT (Regional CRO specialized on Middle East and Africa) to expand “Relieve” phase III HCC study in 3 Middle East countries (Lebanon, Egypt and Saudi Arabia). More information in Onxeo press release: 150326EN_Livatag
MCT inaugurates in March 15 it new Headquarter in Tunisia in Les Berges du Lac 2. Former office has turned too small to host the team that has welcome many new members in 2014. New office will provide more space (around 250m) to the team and allow MCT continue growing in Tunisia. New address will …
All MCT Country Managers were gathered for 2 days of trainings and workshops in Lebanon on September 3rd and September 4th. This 2 day meeting was a perfect opportunity to have everybody on the same place to share good practices. About MCT: MCT is a unique niche …
Country Managers Meeting in Lebanon on early September Read More »
MCT CRA Mariana Alnazer has written an article called “Jordan’s Advancement into the Clinical Market and its Regulatory Framework”. Read her article published in Journal for Clinical studies Volume 6 Issue 4 2014: http://jforcs.com/jcs/ Article ‘Jordan’s Advancement into the Clinical Market’ About MCT: MCT is a unique niche provider CRO, renowned expert of Middle East …
Jordan’s Advancement into the Clinical Market – Article on Journal for Clinical studies Read More »
MCT quality department is welcoming a new member with recruitment of a Quality Coordinator. New Quality coordinator based in Lebanon will support MCT Quality Manager in ensuring quality through permanent update of SOPs, internal Audits and trainings. About MCT: MCT is a unique niche provider CRO, renowned expert of Middle East and North Africa region …
New hire in MCT quality Department as Quality Coordinator Read More »
